Pro Share Advisors LLC Chemo Centryx, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$22.17 - $51.8 $8,180 - $19,114	369 Added 2.92%	13,012 $671,000
Q2 2022 Aug 01, 2022	SELL	$15.36 - $27.51 $72,668 - $130,149	-4,731 Reduced 27.23%	12,643 $313,000
Q1 2022 May 10, 2022	SELL	$22.22 - $39.12 $95,212 - $167,629	-4,285 Reduced 19.78%	17,374 $436,000
Q4 2021 Feb 08, 2022	SELL	$18.38 - $40.5 $3,565 - $7,857	-194 Reduced 0.89%	21,659 $788,000
Q3 2021 Nov 12, 2021	SELL	$13.18 - $19.83 $61,774 - $92,943	-4,687 Reduced 17.66%	21,853 $374,000
Q2 2021 Aug 13, 2021	BUY	$9.59 - $50.88 $35,607 - $188,917	3,713 Added 16.27%	26,540 $355,000
Q1 2021 May 14, 2021	BUY	$49.53 - $68.4 $57,950 - $80,028	1,170 Added 5.4%	22,827 $1.17 Million
Q4 2020 Feb 09, 2021	BUY	$47.25 - $65.16 $211,585 - $291,786	4,478 Added 26.07%	21,657 $1.34 Million
Q3 2020 Nov 13, 2020	BUY	$46.35 - $61.69 $57,983 - $77,174	1,251 Added 7.85%	17,179 $941,000
Q2 2020 Aug 03, 2020	BUY	$38.58 - $65.07 $213,000 - $359,251	5,521 Added 53.05%	15,928 $916,000
Q1 2020 May 15, 2020	SELL	$32.73 - $50.78 $252,577 - $391,869	-7,717 Reduced 42.58%	10,407 $418,000
Q4 2019 Feb 12, 2020	SELL	$6.81 - $39.55 $15,547 - $90,292	-2,283 Reduced 11.19%	18,124 $717,000
Q3 2019 Nov 12, 2019	BUY	$6.47 - $8.96 $7,039 - $9,748	1,088 Added 5.63%	20,407 $138,000
Q2 2019 Aug 13, 2019	SELL	$8.31 - $14.85 $2,384 - $4,261	-287 Reduced 1.46%	19,319 $180,000
Q1 2019 May 15, 2019	BUY	$10.01 - $13.89 $1,111 - $1,541	111 Added 0.57%	19,606 $272,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $34,760 - $46,575	-3,799 Reduced 16.31%	19,495 $213,000
Q3 2018 Nov 14, 2018	SELL	$10.49 - $13.72 $2,591 - $3,388	-247 Reduced 1.05%	23,294 $294,000
Q2 2018 Aug 13, 2018	SELL	$10.62 - $13.98 $22,981 - $30,252	-2,164 Reduced 8.42%	23,541 $310,000
Q1 2018 May 14, 2018	SELL	$5.9 - $14.99 $24,986 - $63,482	-4,235 Reduced 14.14%	25,705 $350,000
Q4 2017 Feb 14, 2018	BUY	$5.53 - $8.42 $4,584 - $6,980	829 Added 2.85%	29,940 $178,000
Q3 2017 Nov 13, 2017	BUY	$6.5 - $10.69 $14,475 - $23,806	2,227 Added 8.28%	29,111 $216,000
Q2 2017 Aug 11, 2017	BUY	N/A	26,884	26,884 $252,000

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account